Prevention of vessel wall damage in experimental irradiation.
D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects*; D001808:Blood Vessels / Q000473:pathology / Q000528:radiation effects*; D002339:Carotid Arteries / Q000473:pathology / Q000528:radiation effects; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology; D005337:Fibrin / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D006025:Glycosaminoglycans / Q000378:metabolism; D006493:Heparin / Q000494:pharmacology; D050356:Lipid Metabolism; D008744:Methylamines / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000528:radiation effects; D011241:Prednisone / Q000494:pharmacology; D011817:Rabbits; D011833:Radiation Injuries, Experimental / Q000473:pathology / Q000517:prevention & control*
D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D006025:Glycosaminoglycans; D008744:Methylamines; D005337:Fibrin; D005340:Fibrinogen; D006493:Heparin; D001241:Aspirin; D011241:Prednisone